RIMASTINA SECADO 100 mg POMADA INTRAMAMARIA
RIMASTINA SECADO 100 mg POMADA INTRAMAMARIA
Authorised
- Rifaximin
Product identification
Medicine name:
RIMASTINA SECADO 100 mg POMADA INTRAMAMARIA
Active substance:
- Rifaximin
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Rifaximin100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Meat and offal0day
-
Milkno withdrawal periodLeche: Cero días tras el parto / 42 días después del tratamiento
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51XX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 2246 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 29/11/2023
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 29/11/2023
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 29/11/2023
es-puar-rimastina-secado-100mg-jeringa-es.pdf
Spanish (PDF)
Download Published on: 9/11/2022